Verition Fund Management
BIIB icon

Verition Fund Management’s Biogen BIIB Stock Holding History

Verition Fund Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,523
Closed -$3.26M – 2373
2025
Q4 		$3.26M Sell
18,523
-11,514
-38% -$1.88M 0.01% 1187
2025
Q3 		$4.21M Buy
30,037
+6,724
+29% +$909K 0.02% 1336
2025
Q2 		$2.93M Sell
23,313
-215,639
-90% -$26.9M 0.01% 1616
2025
Q1 		$32.7M Buy
238,952
+11,822
+5% +$1.69M 0.15% 102
2024
Q4 		$34.7M Buy
227,130
+182,769
+412% +$30.8M 0.14% 106
2024
Q3 		$8.6M Buy
44,361
+27,357
+161% +$5.72M 0.04% 488
2024
Q2 		$3.94M Sell
17,004
-1,229
-7% -$267K 0.02% 863
2024
Q1 		$3.93M Buy
18,233
+1,168
+7% +$274K 0.03% 819
2023
Q4 		$4.42M Sell
17,065
-194,971
-92% -$47.9M 0.03% 491
2023
Q3 		$54.5M Buy
212,036
+41,808
+25% +$11.2M 0.64% 15
2023
Q2 		$48.5M Buy
170,228
+38,018
+29% +$11.3M 0.65% 14
2023
Q1 		$36.8M Buy
132,210
+47,709
+56% +$13.2M 0.51% 15
2022
Q4 		$23.4M Buy
84,501
+13,878
+20% +$3.92M 0.37% 47
2022
Q3 		$18.9M Buy
70,623
+53,506
+313% +$11.4M 0.21% 93
2022
Q2 		$3.49M Sell
17,117
-102,089
-86% -$20.9M 0.07% 396
2022
Q1 		$25.1M Buy
119,206
+89,858
+306% +$19.5M 0.3% 44
2021
Q4 		$7.04M Buy
29,348
+23,146
+373% +$5.95M 0.05% 255
2021
Q3 		$1.75M Buy
6,202
+5,595
+922% +$1.83M 0.02% 716
2021
Q2 		$210K Sell
607
-270
-31% -$81.8K ﹤0.01% 1560
2021
Q1 		$245K Sell
877
-418
-32% -$113K ﹤0.01% 1232
2020
Q4 		$317K Buy
+1,295
New +$334K ﹤0.01% 804
2020
Q1 		– Sell
-21,395
Closed -$6.35M – 631
2019
Q4 		$6.35M Buy
21,395
+17,830
+500% +$4.95M 0.12% 131
2019
Q3 		$830K Sell
3,565
-1,720
-33% -$401K 0.02% 459
2019
Q2 		$1.24M Buy
5,285
+2,133
+68% +$493K 0.03% 364
2019
Q1 		$745K Sell
3,152
-415
-12% -$131K 0.03% 508
2018
Q4 		$1.07M Sell
3,567
-1,604
-31% -$512K 0.08% 243
2018
Q3 		$1.83M Buy
+5,171
New +$1.78M 0.07% 331
2018
Q2 		– Sell
-2,139
Closed -$586K – 1080
2018
Q1 		$586K Buy
+2,139
New +$664K 0.04% 573
2017
Q3 		– Sell
-2,233
Closed -$606K – 1155
2017
Q2 		$606K Buy
2,233
+810
+57% +$214K 0.06% 353
2017
Q1 		$389K Sell
1,423
-8,844
-86% -$2.5M 0.04% 713
2016
Q4 		$2.91M Buy
+10,267
New +$3.04M 0.25% 65
2016
Q3 		– Sell
-2,360
Closed -$571K – 1136
2016
Q2 		$571K Buy
+2,360
New +$622K 0.07% 336
2016
Q1 		– Sell
-1,105
Closed -$339K – 709
2015
Q4 		$339K Buy
+1,105
New +$318K 0.06% 273
2015
Q2 		– Sell
-597
Closed -$252K – 618
2015
Q1 		$252K Sell
597
-2,506
-81% -$988K 0.03% 251
2014
Q4 		$1.05M Buy
3,103
+1,814
+141% +$587K 0.24% 48
2014
Q3 		$426K Sell
1,289
-391
-23% -$129K 0.06% 282
2014
Q2 		$530K Buy
1,680
+483
+40% +$145K 0.06% 248
2014
Q1 		$366K Sell
1,197
-412
-26% -$131K 0.06% 233
2013
Q4 		$450K Sell
1,609
-830
-34% -$215K 0.08% 196
2013
Q3 		$587K Buy
2,439
+1,317
+117% +$295K 0.09% 183
2013
Q2 		$241K Buy
+1,122
New +$240K 0.04% 430

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Verition Fund Management's BIIB Position: Q1 2026 in Review

Verition Fund Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 18,523 shares — an estimated $3.26M sold.

Verition Fund Management first reported a position in BIIB in Q2 2013 and held it in 41 quarters. The position peaked at $54.5M in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Verition Fund Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 18,523 Biogen shares in Q1 2026, an estimated $3.26M.
  • Verition Fund Management first reported a position in Biogen in Q2 2013 and held it in 41 quarters.
  • Verition Fund Management's Biogen position peaked at $54.5M in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.